Cargando...
Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
BACKGROUND: Clozapine (clozaril, Mylan Products Ltd) is a first-choice treatment for people with schizophrenia who have a poor response to standard antipsychotic medication. However, a significant number of patients who trial clozapine have an inadequate response and experience persistent symptoms,...
Guardado en:
| Publicado en: | Health Technol Assess |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
NIHR Journals Library
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6409493/ https://ncbi.nlm.nih.gov/pubmed/30806619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta23070 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|